Another study on 89 patients consisting majorly of adult patients has reported that METTL3/METTL14 are highly expressed in AML with shorter survival in the patients and play an oncogenic role in AML by targeting the mdm2/p53 signaling pathway [13]. The gene discussed is MDM2; the disease is acute myeloid leukemia.